Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - the dynamic peripheral stent and delivery system is indicated for the treatment of de novo or restenotic atherosclerotic lesions in iliac arteries.

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - the ics 3000 implant control system is used to measure and determine electrophysiologic parameters intraoperatively, or in post-implantation follow-up, in conjunction with biotronik pacemaker or defibrillator.

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - biotronik implantable cardioverter defibrillators (icds) are intended to treat life-threatening ventricular arrhythmias with antitachycardia pacing and defibrillation

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - biotronik implantable cardioverter defibrillators (icds) are intended to treat life-threatening ventricular arrhythmias with antitachycardia pacing and defibrillation

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - the pulsar-35 peripheral self expanding stent system is indicated for use in patients with atherosclerotic disease of the femoral and proximal popliteal arteries, in particular for the treatment of insufficient results after percutaneous transluminal angioplasty (pta), e.g. residual stenosis and dissection.

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - in combination with compatible icd, this lead is designed for the following: permanent sensing and pacing in the right ventricle; delivery of defibrillation/cardioversion therapies. with its active fixation screw, this lead is especially suitable for patients with degenerated trabeculae in the ventricle for whom passive fixation with silicone or polyurethane tines is not possible. plexa df-1 s dx leads; plexa s dx 65/15 and plexa s dx 65/17 are also designed for permanent sensing in the right atrium. icd leads with two dipoles for sensing in both chambers are especially indicated for patients who, in addition to the usual icd indications, have documented paroxysmal atrial fibrillation.

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - in combination with a compatible icd, this lead is designed for the following: permanent sensing and pacing in the right ventricle and delivery of defibrillation/cardioversion therapies. with active fixation screw, this lead is especially suitable for patients with degenerated trabeculae in the ventricle for whom passive fixation with silicone or polyurethane tines is not possible

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - the renamic programmer provides communication with the implantable pacemaker or icd during the implantation procedure or follow-ups. the renamic programmer is intended to be used for the following tasks: • conduct sensing, pacing threshold and impedance tests • interrogate data of the implanted device such as program parameters, • recorded statistical data and episodes, as well as real-time iegms • display, printout, save and export data of the implanted device for analysis and reporting purposes • transfer parameters to the implanted device

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - the biotronik safio s lead is only intended for the following: • permanent, transvenous implantation in the right ventricle or right atrium; • use with an implantable pacemaker or a biotronik icd with pacemaker function to constitute an integrated system for permanent cardiac pacing.

Singapore - English - HSA (Health Sciences Authority)

biotronik asia pacific pte. ltd. - cardiovascular - in combination with a compatible implantable triple-chamber pacemaker or icd, this lead is indicated for the following: permanent, transvenous implantation in the coronary venous system via the coronary sinus of the left side of the heart; permanent sensing and pacing of the left ventricle. left ventricular pacing is indicated for patients who need ventricular resynchronization. it can also be an alternative if the use of ventricular endocardial leads is contraindicated due to an artificial tricuspid valve.